Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...
Venus Remedies secures renewed EU GMP certification for its manufacturing facility, enabling expansion in European and global ...
Venus Remedies secures EU GMP renewal from Infarmed, strengthens European market presence: Our Bureau, Bengaluru Wednesday, January 22, 2025, 15:30 Hrs [IST] Venus Remedies has an ...
Imexpharm Corporation has announced its 2024 financial results with net revenue reaching VND2,205 billion, up 10.6 percent ...
Hyderabad: Granules India Limited has announced that the Company's Unit V facility located at Anakapally, Visakhapatnam, ...
The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...
The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...
eVnExpress on MSN10d
Imexpharm achieves VND2,205 billion in net revenue in 2024Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback